Legionnaires' discovery prompts GlaxoSmithKline to idle NC plant

After detecting the bacteria for Legionnaires' disease in a cooling tower, GlaxoSmithKline ($GSK) temporarily closed a manufacturing site in North Carolina. GSK sent employees home while it cleans the tower and investigates. The discovery comes as an outbreak of the infection has resulted in a dozen deaths in New York. More from FiercePharma

Suggested Articles

FDA researchers uncover more concerns and fears among front-line workers and minority groups about a COVID-19 vaccine.

Provention Bio wants to connect the familial threads around Type 1 diabetes with two new campaigns—one targeted at doctors and the other at consumers.

Novartis’ latest campaign with a celebrity dance partner asks people to bust a move to raise awareness around sickle cell anemia and therapy Adakveo.